NCT05726786 - The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) | Biotech Hunter

Enrollment

232

Participants

Timeline

Start Date

April 10, 2023

Primary Completion Date

August 31, 2026

Study Completion Date

October 31, 2026

Conditions

Bladder CancerInterstitial CystitisPainful Bladder SyndromeNeurogenic BladderHemorrhagic CystitisEndometriosisBladder Disease

Interventions

DRUG

Immunonutrition

"Immunonutrition: Oral Impact®, Nestlé Health Science, Switzerland.~IN will be administered as per manufacturer suggestion, i.e. three times a day during 7 days preoperatively. Oral Impact® is a powdered oral feed that provides 309 kcal/bag"

Trial Locations (3)

1011

RECRUITING

Centre Hospitalier Universitaire Vaudois, CHUV, Lausanne

Unknown

NOT_YET_RECRUITING

University Hospital of Bern, Bern

NOT_YET_RECRUITING

Hospital of Riviera-Chablais, Rennaz

All Listed Sponsors

collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

collaborator

Hôpital Riviera-Chablais, Vaud-Valais

OTHER

lead

Centre Hospitalier Universitaire Vaudois

OTHER